Share this post on:

Product Name :
FB418

Search keywords :
LRRK2

drugId :
null

Target Vo:
ABL proto-oncogene 1

Target Vo Short Name :
ABL1

Moa_Name:
ABL proto-oncogene 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
1st Biotherapeutics Inc

Active Company_Name :
1st Biotherapeutics Inc

Active Indication_Name:
Amyotrophic Lateral Sclerosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
8-OHdG (DNA/RNA Damage) Antibody
ERK1/2 Antibody
p53 (acetyl K370)Antibody: p53 (acetyl K370)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to p53(acetyl K370). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related